The metabolism of 9 alpha-fluorinated steroids in the human kidney.
We compared the renal metabolism of 9 alpha-fluorinated steroids with that of the unfluorinated, endogenous steroid cortisol (F). By defining kinetic variables, we characterized isoenzyme activities of 11 beta-hydroxysteroid-dehydrogenase (11 beta-HSD).


METHODS
I) In human kidney slices, we studied the conversion of 9 alpha-fluoro-cortisol (FF) and F to their oxo-products (and vice versa). II) In human kidney microsomes, we performed the kinetic analysis of 11 beta-HSD activity for the steroid pairs F/cortisone (E) and dexamethasone (D)/11-dehydro-dexamethasone (DH-D).


RESULTS
I) In kidney slices, FF is very weakly oxidized to 9 alpha-fluorocortisone (FE), while the reduction of FE to FF is very effective. In contrast, E is hardly reduced to F, but F is strongly inactivated to E. II) Enzyme kinetics in kidney microsomes: 1a) Oxidation of F to E: exclusively NAD-dependent; K(m) = 25.5 nmol/L. b) Reduction of E to F: clearly NADH-preferring; K(m) = 81 nmol/L; Vmax(oxidation) /Vmax(reduction) (F/E) = 26.2a) Oxidation of Dtto DH-D: exclusively NAD-dependent; K(m) = 81 nmol/L b) Reduction of DH-D to D: exclusively NADH-dependent; K(m) = 68 nmol/L; Vmax(oxidation)/Vmax(reduction) (D/DH-D) = 0.09. Thus, the equilibrium of FF/FE in human kidney slices is far on the biologically active hydroxy-side. This shift, induced by the 9-fluorination, gives a good explanation for its mineralocorticoid potency. The cosubstrate dependence and the K(m)-value of the oxidation of F are similar to those of the cloned human 11 beta-HSD-II. For the first time, we could show a NADH-dependent reduction of E to F. Moreover, we found that the preference of D/DH-D for the reductase reaction (see the quotients Vmax(oxidation)/Vmax(reduction)) is due toaa NADH-dependent enzyme (probably 11 beta-HSD-II). These results provide strong evidence against the "dogma" of an "unidirectional" 11 beta-HSD-II.
Diederich
S
S
Dept. of Endocrinology, Klinikum Benjamin Franklin, Freie Universität Berlin.
Hanke
B
B
Bähr
V
V
Oelkers
W
W
D042842:11-beta-Hydroxysteroid Dehydrogenases; D003348:Cortisone / Q000031:analogs & derivatives* / Q000378:metabolism; D003907:Dexamethasone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D006913:Hydroxysteroid Dehydrogenases / Q000378:metabolism*; D007527:Isoenzymes / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology* / Q000648:ultrastructure; D007700:Kinetics; D008861:Microsomes / Q000201:enzymology; D009243:NAD / Q000494:pharmacology; D010084:Oxidation-Reduction
D007527:Isoenzymes; D009243:NAD; C033001:9-fluorocortisone; D003907:Dexamethasone; D006913:Hydroxysteroid Dehydrogenases; D042842:11-beta-Hydroxysteroid Dehydrogenases; D003348:Cortisone; D006854:Hydrocortisone